Pith. sign in

Elijah: Eliminating Backdoors Injected in Diffusion Models via Distribution Shift

1 Pith paper cite this work. Polarity classification is still indexing.

1 Pith paper citing it
abstract

Diffusion models (DM) have become state-of-the-art generative models because of their capability to generate high-quality images from noises without adversarial training. However, they are vulnerable to backdoor attacks as reported by recent studies. When a data input (e.g., some Gaussian noise) is stamped with a trigger (e.g., a white patch), the backdoored model always generates the target image (e.g., an improper photo). However, effective defense strategies to mitigate backdoors from DMs are underexplored. To bridge this gap, we propose the first backdoor detection and removal framework for DMs. We evaluate our framework Elijah on hundreds of DMs of 3 types including DDPM, NCSN and LDM, with 13 samplers against 3 existing backdoor attacks. Extensive experiments show that our approach can have close to 100% detection accuracy and reduce the backdoor effects to close to zero without significantly sacrificing the model utility.

citation-role summary

background 1

citation-polarity summary

fields

cs.CV 1

years

2024 1

verdicts

CONDITIONAL 1

roles

background 1

polarities

unclear 1

representative citing papers

TrojFlow: Flow Models are Natural Targets for Trojan Attacks

cs.CV · 2024-12-21 · conditional · novelty 5.0

TrojFlow fine-tunes a rectified-flow generator so specific trigger-noise inputs produce attacker-chosen images, keeps benign outputs usable, and qualitatively evades UFID and TERD defenses on CIFAR-10 and CelebA.

citing papers explorer

Showing 1 of 1 citing paper.

  • TrojFlow: Flow Models are Natural Targets for Trojan Attacks cs.CV · 2024-12-21 · conditional · none · ref 19 · internal anchor

    TrojFlow fine-tunes a rectified-flow generator so specific trigger-noise inputs produce attacker-chosen images, keeps benign outputs usable, and qualitatively evades UFID and TERD defenses on CIFAR-10 and CelebA.